Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 22001634)

1.

CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer.

Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Kitz J, Becker H, Rüschoff J, Hartmann A, Beissbarth T, Müller-Dornieden A, Ghadimi M, Schneider-Stock R, Gaedcke J.

Surgery. 2012 Apr;151(4):564-70. doi: 10.1016/j.surg.2011.08.013. Epub 2011 Oct 14.

PMID:
22001634
2.

Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.

Shigeyasu K, Nagasaka T, Mori Y, Yokomichi N, Kawai T, Fuji T, Kimura K, Umeda Y, Kagawa S, Goel A, Fujiwara T.

PLoS One. 2015 Jun 29;10(6):e0130409. doi: 10.1371/journal.pone.0130409. eCollection 2015.

3.

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy.

Mitsuhashi K, Yamamoto I, Kurihara H, Kanno S, Ito M, Igarashi H, Ishigami K, Sukawa Y, Tachibana M, Takahashi H, Tokino T, Maruyama R, Suzuki H, Imai K, Shinomura Y, Yamamoto H, Nosho K.

Oncotarget. 2015 Jun 17. [Epub ahead of print]

4.

Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.

Arai E, Gotoh M, Tian Y, Sakamoto H, Ono M, Matsuda A, Takahashi Y, Miyata S, Totsuka H, Chiku S, Komiyama M, Fujimoto H, Matsumoto K, Yamada T, Yoshida T, Kanai Y.

Int J Cancer. 2015 Jun 9. doi: 10.1002/ijc.29630. [Epub ahead of print]

PMID:
26061684
5.

Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.

Kim JH, Cho NY, Bae JM, Kim KJ, Rhee YY, Lee HS, Kang GH.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1920-8. eCollection 2015.

6.

Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype.

Sánchez-Vega F, Gotea V, Margolin G, Elnitski L.

Epigenetics Chromatin. 2015 Apr 17;8:14. doi: 10.1186/s13072-015-0007-7. eCollection 2015.

7.

Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imaging.

Li L, Chen Z, Wang X, Li H, Jiang W, Zhuo S, Guan G, Chen J.

BMC Cancer. 2015 Mar 18;15:142. doi: 10.1186/s12885-015-1157-5.

8.

Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.

Berg M, Nordgaard O, Kørner H, Oltedal S, Smaaland R, Søreide JA, Søreide K.

PLoS One. 2015 Apr 16;10(4):e0122391. doi: 10.1371/journal.pone.0122391. eCollection 2015.

9.

Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.

Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, Tachibana M, Tanuma T, Maguchi H, Shinohara T, Hasegawa T, Imamura M, Kimura Y, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.

Oncotarget. 2015 Mar 30;6(9):7209-20.

10.

Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.

Rhee YY, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH.

Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.

PMID:
25772390
11.

Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.

Mur P, Rodríguez de Lope Á, Díaz-Crespo FJ, Hernández-Iglesias T, Ribalta T, Fiaño C, García JF, Rey JA, Mollejo M, Meléndez B.

J Neurooncol. 2015 May;122(3):441-50. doi: 10.1007/s11060-015-1738-9. Epub 2015 Feb 15.

PMID:
25682093
12.

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Bae JM, Lee TH, Cho NY, Kim TY, Kang GH.

World J Gastroenterol. 2015 Feb 7;21(5):1457-67. doi: 10.3748/wjg.v21.i5.1457.

13.

Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Weisenberger DJ, Levine AJ, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L, Lindor NM, Daftary D, Gallinger S, Selander T, Bapat B, Newcomb PA, Campbell PT, Casey G, Ahnen DJ, Baron JA, Haile RW, Hopper JL, Young JP, Laird PW, Siegmund KD; , for the Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):512-9. doi: 10.1158/1055-9965.EPI-14-1161. Epub 2015 Jan 13.

PMID:
25587051
14.

Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype.

Whitehall VL, Dumenil TD, McKeone DM, Bond CE, Bettington ML, Buttenshaw RL, Bowdler L, Montgomery GW, Wockner LF, Leggett BA.

Epigenetics. 2014 Nov;9(11):1454-60. doi: 10.4161/15592294.2014.971624.

PMID:
25496513
15.

Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.

Laskar RS, Ghosh SK, Talukdar FR.

Mol Carcinog. 2014 Nov 21. doi: 10.1002/mc.22250. [Epub ahead of print]

PMID:
25418895
16.

Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes.

Tian Y, Arai E, Gotoh M, Komiyama M, Fujimoto H, Kanai Y.

BMC Cancer. 2014 Oct 20;14:772. doi: 10.1186/1471-2407-14-772.

17.

A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.

Hokazono K, Ueki T, Nagayoshi K, Nishioka Y, Hatae T, Koga Y, Hirahashi M, Oda Y, Tanaka M.

Oncol Lett. 2014 Nov;8(5):1937-1944. Epub 2014 Aug 8.

18.

Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.

Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen CC.

Oncotarget. 2014 Sep 15;5(17):7342-56.

19.

Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.

Gaedcke J, Leha A, Claus R, Weichenhan D, Jung K, Kitz J, Grade M, Wolff HA, Jo P, Doyen J, Gérard JP, Johnsen SA, Plass C, Beißbarth T, Ghadimi M.

Oncotarget. 2014 Sep 30;5(18):8123-35.

20.

CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China.

Li X, Hu F, Wang Y, Yao X, Zhang Z, Wang F, Sun G, Cui BB, Dong X, Zhao Y.

Biomed Res Int. 2014;2014:236361. doi: 10.1155/2014/236361. Epub 2014 Aug 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk